250 filings
Page 2 of 13
8-K
z7d 130j2qw6b6gd
3 Aug 23
Cara Therapeutics Appoints Helen M. Boudreau to
7:06am
8-K
zppuhhs
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
tu3t42m
15 May 23
Corporate Presentation May 2023
4:21pm
8-K
ohc v0qjpc7eh
15 May 23
Cara Therapeutics Reports First Quarter 2023 Financial Results
4:10pm
ARS
tjwivfej7f auq6hk
20 Apr 23
Annual report to shareholders
4:28pm
DEFA14A
ay7w5igfv8lv
20 Apr 23
Additional proxy soliciting materials
4:24pm
8-K
6cud jxjbqurltakps
23 Mar 23
Corporate Presentation March 2023
5:04pm
8-K
pp9htaqlmmckf
10 Mar 23
Regulation FD Disclosure
5:03pm
S-8
2fhbdlbqyyi1
6 Mar 23
Registration of securities for employees
4:44pm
8-K
ahba qweqv
6 Mar 23
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
v21wxtgc5sjj6qf 9kh
9 Jan 23
Regulation FD Disclosure
7:00am
8-K
l0g vc0pkmi0d6x
7 Nov 22
Regulation FD Disclosure
4:47pm
8-K
9rpfw
7 Nov 22
Cara Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
8-K
12n 6c6aq5f5sx21
3 Nov 22
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
7:12am
8-K
wl4rboo7cdg7nyshs
12 Sep 22
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
6:01am